IGF1 and metabolic syndrome: IGFBP-2 has been found in fact to be possibly the most useful, among other peptides of the IGF system, in assessing nutritional status in preterm neonates during the early postnatal period [26], and in adults a strong association between low IGFBP-2 levels and metabolic syndrome has been identified [27].